Showing results (131-140 of 166) with videos related to
Sort By:
Pageof 17
Blood|July 4, 2001
Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxideP Westervelt, R A Brown, D R Adkins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host diseaseD J Weisdorf, M E Nesbit, N K Ramsay, et al.Blood|November 1, 1988
Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remissionP B McGlave, R J Haake, B C Bostrom, et al.Leukemia & Lymphoma|July 24, 2009
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691S M Smith, J Johnson, B D Cheson, et al.Blood|September 9, 1999
Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantationE Abruzzese, J E Radford, J S Miller, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2010
Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantationS A Giralt, K F Mangan, R T Maziarz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinomaL J Ayash, A Elias, J Ibrahim, et al.Investigational New Drugs|May 24, 2013
A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)Pankaj Gupta, Flora Mulkey, Robert P Hasserjian, et al.Medical and Pediatric Oncology|January 1, 1990
Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell supportD D Hurd, R J Haake, L C Lasky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsC L Shapiro, L Ayash, I J Webb, et al.Pageof 17